TPST-1495 twice daily
TPST-1495-001
Phase 1 small_molecule completed
Quick answer
TPST-1495 twice daily for Solid Tumor is a Phase 1 program (small_molecule) at Tempest Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tempest Therapeutics
- Indication
- Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed